RSV vaccine for babies in limited supply
Beyfortus is used for infants labeled as high-risk and those under six months of age with underlying health conditions.
•
Oct 23, 2023, 11:47 PM
•
Updated 277 days ago
Share:
More Stories
1:46
Nassau DOH: Feral cat found in Cedarhurst tests positive for rabies
21h ago0:34
Northwell Health launches Northwell Studios to develop docuseries and films
yesterday2:42
'Gonna save at least one.' Eastport father who lost daughter to cancer turns grief into helping others
2ds ago2:42
Fitness in 4: Low-impact pool workout
2ds ago1:46
be Well: A machine that can help build your muscles and improve circulation
2ds ago9:58
be Well: Sandra Lindsay shares stories from her inspiring new book
2ds ago1:46
Nassau DOH: Feral cat found in Cedarhurst tests positive for rabies
21h ago0:34
Northwell Health launches Northwell Studios to develop docuseries and films
yesterday2:42
'Gonna save at least one.' Eastport father who lost daughter to cancer turns grief into helping others
2ds ago2:42
Fitness in 4: Low-impact pool workout
2ds ago1:46
be Well: A machine that can help build your muscles and improve circulation
2ds ago9:58
be Well: Sandra Lindsay shares stories from her inspiring new book
2ds agoSupply of Beyfortus, the vaccine used to protect infants against respiratory syncytial virus (RSV), is in limited supply due to high demand, according to the Centers for Disease Control.
Beyfortus is used for infants labeled as high-risk and those under six months of age with underlying health conditions.
